Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol for Cervical Ripening in Postmenopausal Women
NCT00572819Phase 3Completed
- Sponsor
- Ullevål University Hospital
- Start
- Jan 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cervical ripening (CR) comparing Misoprostol with Placebo (2 arms). Primary endpoint: Preoperative baseline cervical dilatation at 24 hours. Started Jan 2008; status: completed.
02
Drugs
misoprostol
03
Conditions
cervical ripening (CR)
Beyond the preview
Go deeper on NCT00572819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00572819.